| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8548 |
| Human Intestinal Absorption | HIA+ | 0.5552 |
| Caco-2 Permeability | Caco2- | 0.7596 |
| P-glycoprotein Substrate | Non-substrate | 0.7148 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9645 |
| Non-inhibitor | 0.8463 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9360 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8424 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8498 |
| CYP450 2D6 Substrate | Non-substrate | 0.9016 |
| CYP450 3A4 Substrate | Non-substrate | 0.7087 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9612 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9707 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9708 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9749 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9894 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9774 |
| Non-inhibitor | 0.9541 |
| AMES Toxicity | Non AMES toxic | 0.8752 |
| Carcinogens | Non-carcinogens | 0.8462 |
| Fish Toxicity | Low FHMT | 0.6924 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9544 |
| Honey Bee Toxicity | High HBT | 0.6108 |
| Biodegradation | Ready biodegradable | 0.9535 |
| Acute Oral Toxicity | III | 0.6726 |
| Carcinogenicity (Three-class) | Non-required | 0.7526 |